ENDS EVALI VALI THCVALI: Difference between revisions

Line 34:

===2022: [https://onlinelibrary.wiley.com/doi/10.1111/add.16097 United States public health officials need to correct e-cigarette health misinformation]===

*Despite the evidence, the CDC continues including ‘e-cigarettes’ in the name EVALI. This naming has affected news coverage and contributed to distorted consumer beliefs about the risks of nicotine vaping. Smokers are twice as likely to incorrectly identify nicotine e-cigarettes as the cause of EVALI than to correctly identify illicit, adulterated THC products.

*'''Despite the evidence, the CDC continues including ‘e-cigarettes’ in the name EVALI. This naming has affected news coverage and contributed to distorted consumer beliefs about the risks of nicotine vaping. Smokers are twice as likely to incorrectly identify nicotine e-cigarettes as the cause of EVALI than to correctly identify illicit, adulterated THC products.'''

*This increased perceived risk is associated with a 30% reduction in both e-cigarette demand and reduced use of e-cigarettes for smoking cessation.

*'''This increased perceived risk is associated with a 30% reduction in both e-cigarette demand and reduced use of e-cigarettes for smoking cessation.'''

**Pesko MF, Cummings KM, Douglas CE, Foulds J, Miller T, Rigotti NA, Warner KE. United States public health officials need to correct e-cigarette health misinformation. Addiction. 2023 May;118(5):785-788. doi: 10.1111/add.16097. Epub 2022 Dec 12. PMID: 36507802.

***Acknowledgment: M.F.P. reports recent funding from the National Institutes of Health, Food and Drug Administration Center for Tobacco Products; American Cancer Society; Virginia Foundation for Healthy Youth; the University of Kentucky’s Institute for the Study of Free Enterprise; and Health Canada. N.A.R.'s research is primarily funded by the National Institutes of Health. She has also received research funding from and consulted with Achieve Life Sciences to evaluate an investigational smoking cessation medication. K.M.C. has served as a paid expert witness in litigation filed against cigarette manufacturers. J.F. has recently performed paid consulting for Johnson & Johnson pharmaceutical company on smoking cessation medicines and has received a research grant from the National Jewish Health (healthcare organization) on telephone smoking cessation counseling. His research on e-cigarettes is funded by the National Institutes of Health (NIDA). C.D. is a co-principal investigator for research conducted through the Center for the Assessment of Tobacco Regulations, which is funded by NIH/FDA. He is also an advisor to the Smoking Cessation Leadership Center at the University of California San Francisco relating to behavioral health and tobacco use. K.E.W.’s research is supported in part by a Tobacco Center of Regulatory Science grant to the University of Michigan and Georgetown University from the Food and Drug Administration and National Cancer Institute (award no. U54CA229974). T.M. is the acting Attorney General for the State of Iowa and is responsible for representing the state in any legal matters. The opinions expressed in this article are the authors’ own and do not necessarily reflect the views of any of the organizations and government agencies that have provided support to the authors.

===2022: [https://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntac088/6562888 Exposure to Negative News Stories About Vaping, and Harm Perceptions of Vaping, Among Youth in England, Canada, and the United States Before and After the Outbreak of E-cigarette or Vaping-Associated Lung Injury (‘EVALI’)]===

*'''These findings are consistent with prior studies finding that media can shape vaping harm perceptions. Media reporting should therefore distinguish between the mode of administration (eg, vaping, smoking) and what is being consumed (eg, nicotine, illicit products). Media coverage and public education campaigns aiming to correct misperceptions of nicotine vaping, including misperceptions of what actually caused ‘EVALI’, may also be helpful.'''

**Citation: Katherine East, Jessica L Reid, Robin Burkhalter, Olivia A Wackowski, James F Thrasher, Harry Tattan-Birch, Christian Boudreau, Maansi Bansal-Travers, Alex C Liber, Ann McNeill, David Hammond, Exposure to Negative News Stories About Vaping, and Harm Perceptions of Vaping, Among Youth in England, Canada, and the United States Before and After the Outbreak of E-cigarette or Vaping-Associated Lung Injury (‘EVALI’), Nicotine & Tobacco Research, Volume 24, Issue 9, September 2022, Pages 1386–1395, https://doi.org/10.1093/ntr/ntac088

*** Acknowledgment: This work was supported by a P01 Grant (1P01CA200512) from the US National Institutes of Health (NIH). Additional support was provided by a Canadian Institutes of Health Research (CIHR)–Public Health Agency of Canada (PHAC) Applied Public Health Research Chair (DH). The February 2020 Wave of the ITC Youth Tobacco and Vaping Survey was funded by a contribution from Health Canada’s Substance Use and Addictions Program (SUAP). KE is the recipient of Fellowship funding from the UK Society for the Study of Addiction (SSA). KE and AM also acknowledge support from Cancer Research UK (RE12936). Contributions by OAW were supported in part by the NIH (R37CA222002). The views expressed herein do not necessarily represent the views of any of the funding agencies. DH has served as a paid expert witness in legal challenges against tobacco and vaping companies.

==Articles, Op-Eds, Blogs, Media==

@@ Line 34: / Line 34: @@
 ===2022: [https://onlinelibrary.wiley.com/doi/10.1111/add.16097 United States public health officials need to correct e-cigarette health misinformation]===
-*Despite the evidence, the CDC continues including ‘e-cigarettes’ in the name EVALI. This naming has affected news coverage and contributed to distorted consumer beliefs about the risks of nicotine vaping. Smokers are twice as likely to incorrectly identify nicotine e-cigarettes as the cause of EVALI than to correctly identify illicit, adulterated THC products.
+*'''Despite the evidence, the CDC continues including ‘e-cigarettes’ in the name EVALI. This naming has affected news coverage and contributed to distorted consumer beliefs about the risks of nicotine vaping. Smokers are twice as likely to incorrectly identify nicotine e-cigarettes as the cause of EVALI than to correctly identify illicit, adulterated THC products.'''
-*This increased perceived risk is associated with a 30% reduction in both e-cigarette demand and reduced use of e-cigarettes for smoking cessation.
+*'''This increased perceived risk is associated with a 30% reduction in both e-cigarette demand and reduced use of e-cigarettes for smoking cessation.'''
 **Pesko MF, Cummings KM, Douglas CE, Foulds J, Miller T, Rigotti NA, Warner KE. United States public health officials need to correct e-cigarette health misinformation. Addiction. 2023 May;118(5):785-788. doi: 10.1111/add.16097. Epub 2022 Dec 12. PMID: 36507802.
 ***Acknowledgment: M.F.P. reports recent funding from the National Institutes of Health, Food and Drug Administration Center for Tobacco Products; American Cancer Society; Virginia Foundation for Healthy Youth; the University of Kentucky’s Institute for the Study of Free Enterprise; and Health Canada. N.A.R.'s research is primarily funded by the National Institutes of Health. She has also received research funding from and consulted with Achieve Life Sciences to evaluate an investigational smoking cessation medication. K.M.C. has served as a paid expert witness in litigation filed against cigarette manufacturers. J.F. has recently performed paid consulting for Johnson & Johnson pharmaceutical company on smoking cessation medicines and has received a research grant from the National Jewish Health (healthcare organization) on telephone smoking cessation counseling. His research on e-cigarettes is funded by the National Institutes of Health (NIDA). C.D. is a co-principal investigator for research conducted through the Center for the Assessment of Tobacco Regulations, which is funded by NIH/FDA. He is also an advisor to the Smoking Cessation Leadership Center at the University of California San Francisco relating to behavioral health and tobacco use. K.E.W.’s research is supported in part by a Tobacco Center of Regulatory Science grant to the University of Michigan and Georgetown University from the Food and Drug Administration and National Cancer Institute (award no. U54CA229974). T.M. is the acting Attorney General for the State of Iowa and is responsible for representing the state in any legal matters. The opinions expressed in this article are the authors’ own and do not necessarily reflect the views of any of the organizations and government agencies that have provided support to the authors.
+===2022: [https://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntac088/6562888 Exposure to Negative News Stories About Vaping, and Harm Perceptions of Vaping, Among Youth in England, Canada, and the United States Before and After the Outbreak of E-cigarette or Vaping-Associated Lung Injury (‘EVALI’)]===
+*'''These findings are consistent with prior studies finding that media can shape vaping harm perceptions. Media reporting should therefore distinguish between the mode of administration (eg, vaping, smoking) and what is being consumed (eg, nicotine, illicit products). Media coverage and public education campaigns aiming to correct misperceptions of nicotine vaping, including misperceptions of what actually caused ‘EVALI’, may also be helpful.'''
+**Citation: Katherine East, Jessica L Reid, Robin Burkhalter, Olivia A Wackowski, James F Thrasher, Harry Tattan-Birch, Christian Boudreau, Maansi Bansal-Travers, Alex C Liber, Ann McNeill, David Hammond, Exposure to Negative News Stories About Vaping, and Harm Perceptions of Vaping, Among Youth in England, Canada, and the United States Before and After the Outbreak of E-cigarette or Vaping-Associated Lung Injury (‘EVALI’), Nicotine & Tobacco Research, Volume 24, Issue 9, September 2022, Pages 1386–1395, https://doi.org/10.1093/ntr/ntac088
+*** Acknowledgment: This work was supported by a P01 Grant (1P01CA200512) from the US National Institutes of Health (NIH). Additional support was provided by a Canadian Institutes of Health Research (CIHR)–Public Health Agency of Canada (PHAC) Applied Public Health Research Chair (DH). The February 2020 Wave of the ITC Youth Tobacco and Vaping Survey was funded by a contribution from Health Canada’s Substance Use and Addictions Program (SUAP). KE is the recipient of Fellowship funding from the UK Society for the Study of Addiction (SSA). KE and AM also acknowledge support from Cancer Research UK (RE12936). Contributions by OAW were supported in part by the NIH (R37CA222002). The views expressed herein do not necessarily represent the views of any of the funding agencies. DH has served as a paid expert witness in legal challenges against tobacco and vaping companies.
 ==Articles, Op-Eds, Blogs, Media==